Business Description
MannKind Corporation is a drug development company focused on improving treatment options for patients living with chronic conditions such as diabetes, pulmonary hypertension, heart failure, and kidney disease. The company sells several approved products, including an inhaled insulin, a wearable insulin delivery device, and medicines for lung and kidney-related conditions. MannKind is also working to bring new treatments to market for rare lung diseases and maintains partnerships with other companies to support its research and commercial efforts. Founded in 1991, the company is based in Danbury, Connecticut.
